RBC Capital raised the firm’s price target on Oxford Biomedica (OXBDF) to 930 GBp from 800 GBp and keeps an Outperform rating on the shares.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OXBDF:
- Oxford Biomedica Director’s Share Transaction Error and Resolution
- Oxford Biomedica Announces New Share Admission on LSE
- Oxford Biomedica’s Chair Increases Stake with Significant Share Purchase
- Oxford Biomedica Raises £60 Million to Expand US Operations
- Oxford Biomedica Announces £60 Million Equity Raise to Expand Global CDMO Network